Medicare Enrolled

Dr. John Favetta, MD

Ophthalmology · North Arlington, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
70 RIDGE RD, North Arlington, NJ 07031
2019972332
Registered in NPPES since 2006
NPI: 1497861090 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Favetta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Favetta? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Favetta

Dr. John Favetta is an ophthalmology specialist in North Arlington, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Favetta performed 1,037 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Favetta received a total of $71,862 from 29 pharmaceutical and/or device companies across 387 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Favetta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 1,037 Medicare services $71,862 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,037
Medicare services
Bottom 25% in NJ for ophthalmology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
737 $74 $248
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
80 $95 $298
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
44 $29 $206
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
42 $27 $90
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
38 $82 $356
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
34 $84 $260
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
29 $27 $43
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
20 $28 $131
Ultrasound scan to determine eye length and lens power
An ultrasound procedure used to measure the length of the eye and calculate the power of the lens.
13 $58 $160
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$71,862
Total received (2018-2024)
Avg $10,266/year across 7 years
Top 4% in NJ for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
387
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$960
2023
$745
2022
$7,826
2021
$12,073
2020
$8,725
2019
$22,864
2018
$18,669

Payments by company (2024)

Bausch & Lomb Americas Inc.
$195
Oyster Point Pharma, Inc.
$176
BIOTISSUE HOLDINGS INC.
$173
SUN PHARMACEUTICAL INDUSTRIES INC.
$170
Tarsus Pharmaceuticals, Inc.
$152
Mallinckrodt Hospital Products Inc.
$36
Thea Pharma Inc.
$25
Harrow Eye, LLC
$18
Alcon Vision LLC
$15
Top 3 companies account for 56.7% of 2024 payments
All-time payments by company (2018-2024) ›
Sun Pharmaceutical Industries Inc.
$24,393
Shire North American Group Inc
$18,268
Kala Pharmaceuticals, Inc.
$14,589
SUN PHARMACEUTICAL INDUSTRIES INC.
$5,865
Dompe US, Inc.
$3,433
Eyevance Pharmaceuticals LLC
$1,518
Aerie Pharmaceuticals, Inc.
$640
Bausch & Lomb Americas Inc.
$557
Bausch & Lomb, a division of Bausch Health US, LLC
$449
Oyster Point Pharma, Inc.
$396
Allergan, Inc.
$307
Glaukos Corporation
$244
Novartis Pharmaceuticals Corporation
$197
BIOTISSUE HOLDINGS INC.
$173
Tarsus Pharmaceuticals, Inc.
$152
EYEVANCE PHARMACEUTICALS LLC
$134
Alcon Vision LLC
$101
BIOTISSUE HOLDINGS, INC.
$83
Mallinckrodt Hospital Products Inc.
$79
Genentech USA, Inc.
$69
Ocular Therapeutix, Inc.
$55
Allergan Inc.
$39
Thea Pharma Inc.
$25
Akorn, Inc.
$25
Harrow Eye, LLC
$18
Horizon Therapeutics plc
$15
TISSUETECH, INC.
$14
Johnson & Johnson Vision Care, Inc.
$14
ABBVIE INC.
$13
Top 3 companies account for 79.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALREX · AMNIOGRAFT · Acuvue · BEPREVE · BESIVANCE · BROMSITE · BTOD · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · CEQUA (cyclosporine ophthalmic solution) 0.09% · COMBIGAN · Cequa · DEXTENZA · DOCTORS ALLERGY FORMULA · DURYSTA · EYSUVIS · Flarex · INFUSE · INVELTYS · IYUZEH · LOTEMAX GEL · LOTEMAX SM · LUMIGAN · MIEBO · OXERVATE · Oxervate · PROKERA · PROLENSA · RESTASIS · RESTASIS MULTIDOSE · Rhopressa · Rocklatan · Simbrinza · TEPEZZA · TRAVATAN Z · TYRVAYA · TobraDex ST · Tobradex ST · VEVYE · VYZULTA · XDEMVY · XIIDRA · ZYLET · Zioptan · iStent inject Trabecular Micro-Bypass Stent System · iStent inject W · rhopressa · rocklatan
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an ophthalmology specialist in North Arlington?
Compare ophthalmologists in the North Arlington area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists in nearby ZIP areas
1,303
County median income
$123,715
Nearest hospital to ZIP centroid (approximate)
CLARA MAASS MEDICAL CENTER
1.9 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Favetta is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Favetta experienced with eye exam, established patient, focused?
Based on Medicare claims data, Dr. Favetta performed 737 eye exam, established patient, focused services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Favetta receive payments from pharmaceutical companies?
Yes. Dr. Favetta received a total of $71,862 from 29 companies across 387 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Favetta's costs compare to other ophthalmologists in North Arlington?
Dr. Favetta's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Favetta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →